Citation: Cl. Kuo et Bn. Ladu, CALCIUM-BINDING BY HUMAN AND RABBIT SERUM PARAOXONASES - STRUCTURAL STABILITY AND ENZYMATIC-ACTIVITY, Drug metabolism and disposition, 26(7), 1998, pp. 653-660
Authors:
AVIRAM M
ROSENBLAT M
BISGAIER CL
NEWTON RS
PRIMOPARMO SL
LADU BN
Citation: M. Aviram et al., PARAOXONASE INHIBITS HIGH-DENSITY-LIPOPROTEIN OXIDATION AND PRESERVESITS FUNCTIONS - A POSSIBLE PEROXIDATIVE ROLE FOR PARAOXONASE, The Journal of clinical investigation, 101(8), 1998, pp. 1581-1590
Authors:
AVIRAM M
ROSENBLAT M
BILLECKE S
EROGAI J
SORENSON R
BISGAIER CL
NEWTON RS
LADU BN
Citation: M. Aviram et al., PARAOXONASE INACTIVATION BY OXIDIZED LDL - ROLE OF THE ENZYMES FREE SULFHYDRYL-GROUP, Circulation, 98(17), 1998, pp. 4201-4201
Citation: Sl. Primoparmo et al., CHARACTERIZATION OF AN UNSTABLE VARIANT (BCHE115D) OF HUMAN BUTYRYLCHOLINESTERASE, Pharmacogenetics, 7(1), 1997, pp. 27-34
Citation: Sl. Primoparmo et al., CHARACTERIZATION OF AN UNSTABLE VARIANT (BCHE115D) OF HUMAN BUTYRYLCHOLINESTERASE, Pharmacogenetics, 7(1), 1997, pp. 27-34
Authors:
HAMALEVY SY
LEITINGER N
WAGNER AC
WATSON AD
VANLENTEN BJ
NAVAB M
LADU BN
BERLINER JA
FOGELMAN AM
Citation: Sy. Hamalevy et al., PARAOXONASE ABOLISHES THE BIOACTIVITY OF SPECIFIC MOLECULES IN MILDLYOXIDIZED LDL, The FASEB journal, 11(3), 1997, pp. 882-882
Authors:
PRIMOPARMO SL
SORENSON RC
LADU BN
NAVAB M
Citation: Sl. Primoparmo et al., ARE THE OTHER PARAOXONASES (PON2 AND PON3) LIKELY TO BE ANTI-ATHEROGENIC, LIKE PON1, The FASEB journal, 10(3), 1996, pp. 3557-3557
Citation: Sl. Primoparmo et al., THE HUMAN SERUM PARAOXONASE ARYLESTERASE GENE (PON1) IS ONE MEMBER OFA MULTIGENE FAMILY, Genomics, 33(3), 1996, pp. 498-507
Citation: Sl. Primoparmo et al., CHARACTERIZATION OF 12 SILENT ALLELES OF THE HUMAN BUTYRYLCHOLINESTERASE (BCHE) GENE, American journal of human genetics, 58(1), 1996, pp. 52-64
Citation: Re. Conn et al., SAFETY ASSESSMENT OF POLYLACTIDE (PLA) FOR USE AS A FOOD-CONTACT POLYMER, Food and chemical toxicology, 33(4), 1995, pp. 273-283
Authors:
SORENSON RC
PRIMOPARMO SL
KUO CL
ADKINS S
LOCKRIDGE O
LADU BN
Citation: Rc. Sorenson et al., RECONSIDERATION OF THE CATALYTIC CENTER AND MECHANISM OF MAMMALIAN PARAOXONASE ARYLESTERASE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(16), 1995, pp. 7187-7191
Authors:
VANLENTEN BJ
HAMA SY
DEBEER FC
STAFFORINI DM
MCINTYRE TM
PRESCOTT SM
LADU BN
FOGELMAN AM
NAVAB M
Citation: Bj. Vanlenten et al., ANTIINFLAMMATORY HDL BECOMES PRO-INFLAMMATORY DURING THE ACUTE-PHASE RESPONSE - LOSS OF PROTECTIVE EFFECT OF HDL AGAINST LDL OXIDATION IN AORTIC-WALL CELL COCULTURES, The Journal of clinical investigation, 96(6), 1995, pp. 2758-2767
Authors:
WATSON AD
BERLINER JA
HAMA SY
LADU BN
FAULL KF
FOGELMAN AM
NAVAB M
Citation: Ad. Watson et al., PROTECTIVE EFFECT OF HIGH-DENSITY-LIPOPROTEIN ASSOCIATED PARAOXONASE - INHIBITION OF THE BIOLOGICAL-ACTIVITY OF MINIMALLY OXIDIZED LOW-DENSITY-LIPOPROTEIN, The Journal of clinical investigation, 96(6), 1995, pp. 2882-2891
Authors:
WATSON AD
NAVAB M
HAMA SY
SEVANIAN A
PRESCOTT SM
STAFFORINI DM
MCINTYRE TM
LADU BN
FOGELMAN AM
BERLINER JA
Citation: Ad. Watson et al., EFFECT OF PLATELET-ACTIVATING FACTOR-ACETYLHYDROLASE ON THE FORMATIONAND ACTION OF MINIMALLY OXIDIZED LOW-DENSITY-LIPOPROTEIN, The Journal of clinical investigation, 95(2), 1995, pp. 774-782
Citation: Bn. Ladu et S. Primoparmo, REDUCED CHOLINESTERASE ACTIVITY DUE TO QUANTITATIVE AND QUALITATIVE VARIANTS - CLINICAL IMPLICATIONS, Anesthesiology, 83(3A), 1995, pp. 338-338
Authors:
GREENBERG CP
PRIMOPARMO SL
PANTUCK EJ
LADU BN
Citation: Cp. Greenberg et al., PROLONGED RESPONSE TO SUCCINYLCHOLINE - A NEW VARIANT OF PLASMA CHOLINESTERASE THAT IS IDENTIFIED AS NORMAL BY TRADITIONAL PHENOTYPING METHODS, Anesthesia and analgesia, 81(2), 1995, pp. 419-421
Citation: Bn. Ladu, BUTYRYLCHOLINESTERASE VARIANTS AND THE NEW METHODS OF MOLECULAR-BIOLOGY, Acta anaesthesiologica Scandinavica, 39(2), 1995, pp. 139-141